Lantero Rodriguez, Juan
Karikari, Thomas K.
Suárez-Calvet, Marc
Troakes, Claire
King, Andrew
Emersic, Andreja
Aarsland, Dag
Hye, Abdul
Zetterberg, Henrik
Blennow, Kaj
Ashton, Nicholas J. http://orcid.org/0000-0002-6353-9316
Article History
Received: 4 June 2020
Revised: 15 July 2020
Accepted: 15 July 2020
First Online: 27 July 2020
Compliance with ethical standard
:
: HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. KB has served as a consultant or at advisory boards for Axon, Biogen, CogRx, Lilly, MagQu, Novartis and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. The other authors declare no competing interest.